<DOC>
	<DOCNO>NCT02644473</DOCNO>
	<brief_summary>To evaluate whether difference symptomatic thromboembolism event subset patient history , risk factor thromboembolic disease topically apply tranexamic acid total joint arthroplasty .</brief_summary>
	<brief_title>Safety Topical Tranexamic Acid Total Joint Arthroplasty High Risk Patients</brief_title>
	<detailed_description>Tranexamic acid ( TXA ) use successfully stop bleeding dental procedure , removal tonsil , prostate surgery , heavy menstrual bleeding , eye injury , well patient hemophilia . Intravenous TXA also show reduce blood loss , reduce transfusion requirement , decrease length stay patient undergoing total knee arthroplasty total hip arthroplasty . These benefit occur without increase risk thromboembolism event pulmonary embolism , deep venous thrombosis , myocardial infarction , cerebrovascular event patient without history , risk factor thromboembolic disease . Topical TXA TJA also demonstrate show benefit without increase risk , well systemic absorption medication effective therapeutic plasma concentration . Preliminary retrospective study demonstrate IV TXA safe effective patient risk factor thromboembolic event patient American Society Anesthesiologists score III IV . Currently , prospective study use either IV topical TXA high risk patient . The goal study evaluate whether difference symptomatic thromboembolism event subset patient history , risk factor thromboembolic disease topically apply TXA total joint arthroplasty ( TJA ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Presence one seven risk factor thromboembolic event Prior DVT , PE , MI , CVA , coronary artery stent placement , CABG , prothrombotic condition ( Factor V Leiden deficiency , protein C deficiency , antiphospholipid syndrome , etc ) . Simultaneous bilateral , hip resurfacing , partial knee , revision arthroplasty</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>